Presented here are few of the products which Vertex Product Development has designed, engineered and developed from conception to production for the Consumer, Commercial, Industrial and Medical industries.
Presented here are few of the products which Vertex Product Development has designed, engineered and developed from conception to production for the Consumer, Commercial, Industrial and Medical industries.
Vertex was approached by the client to do a complete re-design of an existing similar product manufactured by the same client, and to have a new product which is more up to date with regards to design style and lower in cost to manufacture.
Raga Khambaj by RANJAN MAHARAJ. Ranjan Maharaj is one of the rare talented unparallel traditional Sitar players of India. He is presently a regular artist of All India Radio (A.I.R). His real name is Ranjan Roy,but he was honoured with the title \'Maharaj\' meaning The King. This video was recorded at The Dyol Music Festival,Singapore,Little India.This is an editted version to fit in youtube.com, as because this video was a three hours long continuous Sitar play by Ranjan Maharaj.
This raga Khammaj, is played in a very rare exotic style,which is specially boldly wittnessed during the last few minutes of the video.
RANJAN MAHARAJ is a live performer & travels through out the world to perform in his Sitar. To contact RANJAN MAHARAJ -
musicianranjan@yahoo.com
IT WOULD BE REALLY OBLIGING FROM THE HEART TO ALL MY VIEWERS OF THIS VIDEO IF YOU PLEASE COMMENT ON THIS SITAR PLAYING,even a single word will be truely valuable and appreciated.
VISIT THE PERSONAL WEB SITE OF SITAR MAESTRO RANJAN -
http://www.indianclassicalmusician.blogspot.com/
To view the \'Pandit Ranjan Maharaj fan club\' community page,in Google,please visit:
http://www.orkut.co.in/Community.aspx?cmm=60522626&mt=7
India tour is one of the unforgettable experiences which you would cherish in your mind forever. India is one of the countries that enhance the beauty of the world with its fascinating natural wonders. No other country in the world can match up to India’s diverse culture, from North to south and east to west, every region is marked by its own distinctive cultural identity. Our India tour packages offer you to experience all of the attractive features of this enchanting country. Our tour packages are designed by travel experts, which let you experience the best of India. India showers her wide range of attractions that on its visitors are beyond description but still with each of our tour package we try to highlight as well as describe each of its mysterious features of this incredible land.
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries.2 In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are needed to address them.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60637-astellas-report-diagnosis-management-CDI
Toyota Motor Corporation (Toyota) has launched “Start Your Impossible” – a global corporate initiative that aims to inspire Toyota employees, partners, and customers and connect them with the company’s core beliefs. In an age of accelerating technological and environmental developments, “Start Your Impossible” marks Toyota’s commitment to support the creation of a more inclusive and sustainable society in which everyone can challenge their impossible.
Toyota believes that mobility goes beyond cars; it is about overcoming challenges and making dreams come true. The “Start Your Impossible” initiative reflects these values and highlights the company’s goal to provide freedom of mobility for all. “We want to share this thinking with all stakeholders, including consumers, so that we can approach this challenge together,” said Toyota President, Akio Toyoda.
To view the multimedia release go to:
https://www.multivu.com/players/English/8193651-toyota-global-campaign-for-olympic-paralympic-games/
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
The Chevrolet Equinox and its twin, the GMC Terrain, are the only midsize SUVs out of nine evaluated to earn a good rating in the Insurance Institute for Highway Safety’s small overlap front crash test, which continues to challenge manufacturers more than a year and a half after its introduction.
The Equinox and the Terrain qualify for the Institute’s highest award for 2014, TOP SAFETY PICK+. The Toyota Highlander, a midsize SUV whose acceptable small overlap rating was announced in December, also qualifies. The award is given to vehicles with a good or acceptable small overlap rating, good ratings in four other occupant protection tests, and a rating of basic or higher for front crash prevention.
Three other midsize SUVs in the test group rate poor for small overlap protection, and three are marginal.
The 2014 Subaru Forester is the first vehicle to ace every aspect of the challenging small overlap front crash test conducted by the Insurance Institute for Highway Safety (IIHS). The Forester, the only 1 of 13 small SUVs to earn an overall rating of good in the test, and the 2013 Mitsubishi Outlander Sport, which earns acceptable, are the latest vehicles to qualify for the Institute’s recently inaugurated top honor, TOP SAFETY PICK+. Each of the other 11 SUVs earns either a poor or marginal rating.
